
Last update at 2026-06-23T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
INNOVATE Corp. Announces First Quarter 2025 Results
Tue 06 May 25, 08:05 PMINNOVATE Corp. to Report First Quarter 2025 Results on May 6th
Wed 16 Apr 25, 08:05 PMINNOVATE Corp. to Report Fourth Quarter and Full Year 2024 Results on March 31st
Thu 27 Feb 25, 09:02 PMMediBeacon® Transdermal GFR System receives device approval in China
Tue 25 Feb 25, 02:00 PMMediBeacon® Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Fri 17 Jan 25, 11:18 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | -41.10000M | -80.70000M | -27.80000M | -37.10000M | 182.30M |
| Minority interest | 6.10M | 8.70M | 45.70M | 105.10M | 113.60M |
| Net income | -42.00000M | -86.30000M | -38.30000M | -16.80000M | 162.00M |
| Selling general administrative | 180.10M | 168.30M | 181.10M | 190.10M | 218.40M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 221.40M | 183.70M | 167.30M | 279.30M | 194.20M |
| Reconciled depreciation | 42.20M | 37.60M | 5.90M | 41.10M | 38.70M |
| Ebit | 13.40M | -9.10000M | 77.70M | 95.80M | 38.30M |
| Ebitda | 38.10M | 16.30M | 74.50M | 111.20M | 70.00M |
| Depreciation and amortization | 24.70M | 25.40M | -3.20000M | 15.40M | 31.70M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 13.40M | -9.10000M | 77.70M | 95.80M | -55.80000M |
| Other operating expenses | 1623.90M | 1215.80M | 996.40M | 1723.60M | 2032.50M |
| Interest expense | 52.00M | 59.10M | 79.40M | 79.50M | 75.70M |
| Tax provision | 0.90M | 5.60M | 10.50M | -20.60000M | 2.40M |
| Interest income | - | - | - | - | - |
| Net interest income | -52.00000M | -59.10000M | -79.40000M | -95.10000M | -75.70000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 0.90M | 5.60M | 10.50M | -20.30000M | 2.40M |
| Total revenue | 1637.30M | 1205.20M | 1005.80M | 1811.60M | 1976.70M |
| Total operating expenses | 208.00M | 194.30M | 157.90M | 191.30M | 250.00M |
| Cost of revenue | 1415.90M | 1021.50M | 838.50M | 1532.30M | 1782.50M |
| Total other income expense net | -54.50000M | -71.60000M | -105.50000M | -132.90000M | 313.80M |
| Discontinued operations | - | -149.90000M | -63.80000M | -13.90000M | -13.90000M |
| Net income from continuing ops | -42.00000M | -86.30000M | -38.30000M | -36.10000M | 179.90M |
| Net income applicable to common shares | -40.80000M | -229.70000M | -94.80000M | -31.50000M | 139.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1151.70M | 1080.60M | 6742.80M | 6958.30M | 6503.80M |
| Intangible assets | 190.10M | 208.40M | 174.60M | 221.70M | 219.20M |
| Earning assets | - | - | - | - | - |
| Other current assets | 16.80M | 10.90M | 116.50M | 300.70M | 1.30M |
| Total liab | 1181.30M | 1068.70M | 6137.30M | 6503.40M | 6302.10M |
| Total stockholder equity | -103.70000M | -65.50000M | 559.80M | 349.80M | 88.10M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 85.50M | 111.70M | 74.70M | 153.90M | 240.20M |
| Common stock | 0.10M | 0.10M | 0.10M | - | - |
| Capital stock | 0.10M | 18.90M | 0.10M | 0.00000M | 0.00000M |
| Retained earnings | -452.10000M | -416.20000M | -188.70000M | -96.70000M | -57.20000M |
| Other liab | 26.50M | 13.90M | 5241.50M | 5189.70M | 5184.60M |
| Good will | 127.10M | 127.40M | 111.00M | 112.50M | 171.70M |
| Other assets | 19.10M | 18.00M | 65.50M | 74.10M | 109.30M |
| Cash | 80.40M | 45.50M | 232.30M | 228.80M | 325.00M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 417.20M | 439.50M | 251.00M | 524.00M | 344.90M |
| Current deferred revenue | 98.60M | 79.10M | -53.70000M | 171.60M | - |
| Net debt | 634.00M | 580.80M | 329.20M | 544.80M | 418.90M |
| Short term debt | 30.60M | 69.50M | 53.70M | 63.90M | - |
| Short long term debt | 30.60M | 69.50M | 53.70M | 63.90M | - |
| Short long term debt total | 714.40M | 626.30M | 561.50M | 773.60M | 743.90M |
| Other stockholder equity | 324.80M | 325.40M | 341.10M | 267.50M | 237.60M |
| Property plant equipment | 230.80M | 239.50M | 158.20M | 176.90M | 376.30M |
| Total current assets | 536.40M | 442.60M | 6032.00M | 6049.10M | 5253.40M |
| Long term investments | 48.20M | 56.00M | 134.50M | 177.50M | 273.00M |
| Net tangible assets | -438.50000M | -420.10000M | 274.20M | 28.80M | -302.80000M |
| Short term investments | - | - | 4456.10M | 4028.90M | 3391.60M |
| Net receivables | 420.00M | 365.70M | 1217.20M | 1468.10M | 1536.80M |
| Long term debt | 683.80M | 556.80M | 507.00M | 740.80M | 703.50M |
| Inventory | 18.90M | 17.00M | 9.90M | 22.60M | -1.30000M |
| Accounts payable | 202.50M | 179.20M | 176.30M | 134.60M | 104.70M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | 5.90M | 6.40M | 396.90M | 168.70M | -112.60000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | 0.10M | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 71.90M | 73.30M | 172.40M | 188.00M | 208.10M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 615.30M | 638.00M | 710.80M | 909.20M | 1250.40M |
| Capital lease obligations | 53.80M | 58.50M | 0.80M | 34.60M | 40.40M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -22.50000M | -223.20000M | 8.60M | -187.90000M | -853.50000M |
| Change to liabilities | 41.20M | 65.10M | 1.30M | -18.00000M | 6.60M |
| Total cashflows from investing activities | -22.50000M | -223.20000M | 162.30M | -263.60000M | -224.60000M |
| Net borrowings | 74.00M | 29.50M | -185.90000M | 59.40M | 153.60M |
| Total cash from financing activities | 68.10M | 4.30M | -204.60000M | 62.40M | 115.20M |
| Change to operating activities | -7.30000M | 5.70M | 41.50M | 47.10M | 353.60M |
| Net income | -42.00000M | -86.30000M | -102.10000M | -36.10000M | 179.90M |
| Change in cash | 34.70M | 2.20M | 38.70M | -90.90000M | 231.50M |
| Begin period cash flow | 47.50M | 45.30M | 195.10M | 321.30M | 98.90M |
| End period cash flow | 82.20M | 47.50M | 233.80M | 230.40M | 330.40M |
| Total cash from operating activities | -9.50000M | 27.00M | 41.70M | 110.50M | 341.40M |
| Issuance of capital stock | 0.00000M | 10.50M | 71.50M | 8.90M | - |
| Depreciation | 42.20M | 37.60M | 5.90M | 15.40M | 38.70M |
| Other cashflows from investing activities | -3.80000M | -157.80000M | -17.00000M | -46.00000M | -1.40000M |
| Dividends paid | -5.20000M | -62.50000M | 2.90M | 2.90M | 2.00M |
| Change to inventory | -1.90000M | -13.40000M | -18.80000M | 3.40M | 226.90M |
| Change to account receivables | -5.50000M | -38.30000M | 43.00M | 29.60M | -30.20000M |
| Sale purchase of stock | 0.00000M | -10.40000M | 0.00000M | -8.30000M | -5.80000M |
| Other cashflows from financing activities | 186.70M | 472.80M | -53.20000M | 104.50M | -30.60000M |
| Change to netincome | 0.80M | 193.00M | 26.50M | 103.80M | -196.70000M |
| Capital expenditures | 20.70M | 24.10M | 17.80M | 25.80M | 39.70M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -20.00000M | 13.40M | 85.80M | 41.80M | 330.00M |
| Stock based compensation | 2.40M | 2.40M | 2.90M | 6.30M | 9.00M |
| Other non cash items | 6.80M | 57.90M | 41.10M | 111.20M | -213.60000M |
| Free cash flow | -30.20000M | 2.90M | 23.90M | 84.70M | 301.70M |
Sector: Industrials Industry: Engineering & Construction
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| VATE Innovate Corp |
-0.07 0.38% | 18.13 | - | - | 0.06 | 0.74 | 0.58 | 12.52 |
| VCISF VINCI SA |
- -% | 148.71 | 14.66 | 12.94 | 1.06 | 2.37 | 1.40 | 8.24 |
| VCISY Vinci SA ADR |
-0.54 1.45% | 36.70 | 14.51 | 12.97 | 1.07 | 2.38 | 1.40 | 8.26 |
| FIX Comfort Systems USA Inc |
-158.44 7.67% | 1908.07 | 57.81 | 47.39 | 6.47 | 24.14 | 6.44 | 40.64 |
| LTOUF Larsen & Toubro Limited |
- -% | 41.95 | 40.39 | 28.41 | 0.03 | 6.23 | 0.03 | 0.25 |
INNOVATE Corp., through its subsidiaries, operates in infrastructure, life sciences, and spectrum areas in the United States. The Infrastructure segment provides industrial construction, structural steel, and facility maintenance services, such as fabrication and erection of structural steel and heavy steel plate services, and large-diameter water pipes and water storage tanks; fabrication of trusses and girders; and 3-D building information modeling and detailing for commercial, industrial, and infrastructure construction projects, such as buildings and office complexes, hotels and casinos, convention centers, sports arenas and stadiums, shopping malls, hospitals, dams, bridges, mines, metal processing, refineries, pulp and paper mills, and power plants. This segment also offers solutions for digital engineering, modeling and detailing, construction, and heavy equipment installation and facility services including maintenance, repair, and installation; and manufactures pollution control scrubbers, tunnel liners, pressure vessels, strainers, filters, separators, and customized products. The Life Sciences segment develops products to treat early osteoarthritis of the knee; and aesthetic and medical technologies for the skin. The Spectrum segment operates over-the-air broadcasting stations across the United States; and Azteca America, a Spanish-language broadcast network. The company was formerly known as HC2 Holdings, Inc. and changed its name to INNOVATE Corp. in September 2021. The company was incorporated in 1994 and is headquartered in New York, New York.
295 Madison Avenue, New York, NY, United States, 10017
| Name | Title | Year Born |
|---|---|---|
| Mr. Wayne Barr Jr. | CEO, Pres & Director | 1964 |
| Mr. Michael J. Sena | Chief Financial Officer | 1973 |
| Ms. Suzi Raftery Herbst | Chief Operating Officer | 1976 |
| Anthony Rozmus | Investor Relations Officer | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.